Original article

Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland

AJ Palmer, S Roze, WJ Valentine, JA Ray

DOI: https://doi.org/10.4414/smw.2006.11337
Publication Date: 23.12.2005
Swiss Med Wkly. 2006;136(-1-00):346